<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38255826</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">753</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25020753</ELocationID><Abstract><AbstractText>Aging induces numerous physiological alterations, with immunosenescence emerging as a pivotal factor. This phenomenon has attracted both researchers and clinicians, prompting profound questions about its implications for health and disease. Among the contributing factors, one intriguing actor in this complex interplay is human cytomegalovirus (CMV), a member of the herpesvirus family. Latent CMV infection exerts a profound influence on the aging immune system, potentially contributing to age-related diseases. This review delves into the intricate relationship between immunosenescence and CMV, revealing how chronic viral infection impacts the aging immune landscape. We explore the mechanisms through which CMV can impact both the composition and functionality of immune cell populations and induce shifts in inflammatory profiles with aging. Moreover, we examine the potential role of CMV in pathologies such as cardiovascular diseases, cancer, neurodegenerative disorders, COVID-19, and Long COVID. This review underlines the importance of understanding the complex interplay between immunosenescence and CMV. It offers insights into the pathophysiology of aging and age-associated diseases, as well as COVID-19 outcomes among the elderly. By unraveling the connections between immunosenescence and CMV, we gain a deeper understanding of aging's remarkable journey and the profound role that viral infections play in transforming the human immune system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Human Development, Lentzeallee 94, 14195 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Benedetto</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Human Development, Lentzeallee 94, 14195 Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003587" MajorTopicYN="N">Cytomegalovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068884" MajorTopicYN="Y">Immunosenescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003586" MajorTopicYN="Y">Cytomegalovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085343" MajorTopicYN="Y">Latent Infection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMV latency</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">age-related diseases</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">cytomegalovirus</Keyword><Keyword MajorTopicYN="N">immunosenescence</Keyword><Keyword MajorTopicYN="N">inflammaging</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38255826</ArticleId><ArticleId IdType="pmc">PMC10815036</ArticleId><ArticleId IdType="doi">10.3390/ijms25020753</ArticleId><ArticleId IdType="pii">ijms25020753</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pawelec G. Age and immunity: What is &#x201c;immunosenescence&#x201d;? Exp. Gerontol. 2018;105:4&#x2013;9. doi: 10.1016/j.exger.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.10.024</ArticleId><ArticleId IdType="pubmed">29111233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J. The twilight of immunity: Emerging concepts in aging of the immune system. Nat. Immunol. 2018;19:10&#x2013;19. doi: 10.1038/s41590-017-0006-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0006-x</ArticleId><ArticleId IdType="pubmed">29242543</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangrazzi L., Weinberger B. T cells, aging and senescence. Exp. Gerontol. 2020;134:110887. doi: 10.1016/j.exger.2020.110887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.110887</ArticleId><ArticleId IdType="pubmed">32092501</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S., Pawelec G. The Immune System and Its Dysregulation with Aging. Subcell. Biochem. 2019;91:21&#x2013;43. doi: 10.1007/978-981-13-3681-2_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-3681-2_2</ArticleId><ArticleId IdType="pubmed">30888648</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Fulop T., Pawelec G. Immunosenescence in vertebrates and invertebrates. Immun. Ageing. 2013;10:12. doi: 10.1186/1742-4933-10-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-10-12</ArticleId><ArticleId IdType="pmc">PMC3637519</ArticleId><ArticleId IdType="pubmed">23547999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Liang Q., Ren Y., Guo C., Ge X., Wang L., Cheng Q., Luo P., Zhang Y., Han X. Immunosenescence: Molecular mechanisms and diseases. Signal Transduct. Target. Ther. 2023;8:200. doi: 10.1038/s41392-023-01451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01451-2</ArticleId><ArticleId IdType="pmc">PMC10182360</ArticleId><ArticleId IdType="pubmed">37179335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelbrunn M., Kroemer G. Hallmarks of T cell aging. Nat. Immunol. 2021;22:687&#x2013;698. doi: 10.1038/s41590-021-00927-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00927-z</ArticleId><ArticleId IdType="pubmed">33986548</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244&#x2013;254. doi: 10.1111/j.1749-6632.2000.tb06651.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A., Farzaneh F., Candore G., Caruso C., Davinelli S., Gambino C.M., Ligotti M.E., Zareian N., Accardi G. Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention. Front. Immunol. 2019;10:2247. doi: 10.3389/fimmu.2019.02247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02247</ArticleId><ArticleId IdType="pmc">PMC6773825</ArticleId><ArticleId IdType="pubmed">31608061</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19. Int. J. Mol. Sci. 2021;22:12539. doi: 10.3390/ijms222212539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212539</ArticleId><ArticleId IdType="pmc">PMC8618618</ArticleId><ArticleId IdType="pubmed">34830421</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S., Derhovanessian E., Steinhagen-Thiessen E., Goldeck D., Muller L., Pawelec G. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: Results from the Berlin BASE-II Study. Biogerontology. 2015;16:631&#x2013;643. doi: 10.1007/s10522-015-9563-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-015-9563-2</ArticleId><ArticleId IdType="pubmed">25732234</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S., Gaetjen M., Muller L. The Modulatory Effect of Gender and Cytomegalovirus-Seropositivity on Circulating Inflammatory Factors and Cognitive Performance in Elderly Individuals. Int. J. Mol. Sci. 2019;20:990. doi: 10.3390/ijms20040990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20040990</ArticleId><ArticleId IdType="pmc">PMC6412896</ArticleId><ArticleId IdType="pubmed">30823516</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths P., Baraniak I., Reeves M. The pathogenesis of human cytomegalovirus. J. Pathol. 2015;235:288&#x2013;297. doi: 10.1002/path.4437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4437</ArticleId><ArticleId IdType="pubmed">25205255</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath J.J., Michael D. The Immune Response Against Human Cytomegalovirus Links Cellular to Systemic Senescence. Cells. 2020;9:766. doi: 10.3390/cells9030766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9030766</ArticleId><ArticleId IdType="pmc">PMC7140628</ArticleId><ArticleId IdType="pubmed">32245117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambari S., Klenerman P., Pollard A.J. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV. Rev. Med. Virol. 2020;30:e2144. doi: 10.1002/rmv.2144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2144</ArticleId><ArticleId IdType="pmc">PMC7404358</ArticleId><ArticleId IdType="pubmed">32671966</ArticleId></ArticleIdList></Reference><Reference><Citation>La Rosa C., Diamond D.J. The immune response to human CMV. Future Virol. 2012;7:279&#x2013;293. doi: 10.2217/fvl.12.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.12.8</ArticleId><ArticleId IdType="pmc">PMC3539762</ArticleId><ArticleId IdType="pubmed">23308079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathei C., Vaes B., Wallemacq P., Degryse J. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J. Am. Geriatr. Soc. 2011;59:2201&#x2013;2208. doi: 10.1111/j.1532-5415.2011.03719.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2011.03719.x</ArticleId><ArticleId IdType="pubmed">22092044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikby A., Johansson B., Olsson J., Lofgren S., Nilsson B.O., Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: The Swedish NONA immune study. Exp. Gerontol. 2002;37:445&#x2013;453. doi: 10.1016/S0531-5565(01)00212-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(01)00212-1</ArticleId><ArticleId IdType="pubmed">11772532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Klein S.L., Garibaldi B.T., Li H., Wu C., Osevala N.M., Li T., Margolick J.B., Pawelec G., Leng S.X. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res. Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubev A.G. COVID-19: A Challenge to Physiology of Aging. Front. Physiol. 2020;11:584248. doi: 10.3389/fphys.2020.584248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.584248</ArticleId><ArticleId IdType="pmc">PMC7745705</ArticleId><ArticleId IdType="pubmed">33343386</ArticleId></ArticleIdList></Reference><Reference><Citation>Koff W.C., Williams M.A. Covid-19 and Immunity in Aging Populations&#x2014;A New Research Agenda. N. Engl. J. Med. 2020;383:804&#x2013;805. doi: 10.1056/NEJMp2006761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2006761</ArticleId><ArticleId IdType="pubmed">32302079</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo N., Zhang R., Ueno H., Yamamoto T., Weiskopf D., Nagao M., Yamanaka S., Hamazaki Y. Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals. Front. Aging. 2021;2:719342. doi: 10.3389/fragi.2021.719342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2021.719342</ArticleId><ArticleId IdType="pmc">PMC9261342</ArticleId><ArticleId IdType="pubmed">35822004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P. &#x201c;The ancient and the new&#x201d;: Is there an interaction between cytomegalovirus and SARS-CoV-2 infection? Immun. Ageing. 2020;17:14. doi: 10.1186/s12979-020-00185-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00185-x</ArticleId><ArticleId IdType="pmc">PMC7251217</ArticleId><ArticleId IdType="pubmed">32501397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong D.S.Y., Spitoni C., Klein Klouwenberg P.M.C., Verduyn Lunel F.M., Frencken J.F., Schultz M.J., van der Poll T., Kesecioglu J., Bonten M.J.M., Cremer O.L. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome. Intensive Care Med. 2016;42:333&#x2013;341. doi: 10.1007/s00134-015-4071-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4071-z</ArticleId><ArticleId IdType="pmc">PMC4747999</ArticleId><ArticleId IdType="pubmed">26415682</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Pawelec G., Khalil A., Cohen A.A., Hirokawa K., Witkowski J.M., Franceschi C. Immunology of Aging: The Birth of Inflammaging. Clin. Rev. Allergy Immunol. 2021;64:109&#x2013;122. doi: 10.1007/s12016-021-08899-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08899-6</ArticleId><ArticleId IdType="pmc">PMC8449217</ArticleId><ArticleId IdType="pubmed">34536213</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J. Pathol. 2007;211:144&#x2013;156. doi: 10.1002/path.2104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2104</ArticleId><ArticleId IdType="pmc">PMC1931833</ArticleId><ArticleId IdType="pubmed">17200946</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D., Weinberger B., Grubeck-Loebenstein B. The aging of the immune system. Transpl. Int. 2009;22:1041&#x2013;1050. doi: 10.1111/j.1432-2277.2009.00927.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-2277.2009.00927.x</ArticleId><ArticleId IdType="pubmed">19624493</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodig S., Cepelak I., Pavic I. Hallmarks of senescence and aging. Biochem. Med. 2019;29:030501. doi: 10.11613/BM.2019.030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2019.030501</ArticleId><ArticleId IdType="pmc">PMC6610675</ArticleId><ArticleId IdType="pubmed">31379458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Weyand C.M., Goronzy J.J. Hallmarks of the aging T-cell system. FEBS J. 2021;288:7123&#x2013;7142. doi: 10.1111/febs.15770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15770</ArticleId><ArticleId IdType="pmc">PMC8364928</ArticleId><ArticleId IdType="pubmed">33590946</ArticleId></ArticleIdList></Reference><Reference><Citation>Weksler M.E. Changes in the B-cell repertoire with age. Vaccine. 2000;18:1624&#x2013;1628. doi: 10.1016/S0264-410X(99)00497-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(99)00497-1</ArticleId><ArticleId IdType="pubmed">10689139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Geiger H., Rudolph K.L. Immunoaging induced by hematopoietic stem cell aging. Curr. Opin. Immunol. 2011;23:532&#x2013;536. doi: 10.1016/j.coi.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.05.004</ArticleId><ArticleId IdType="pubmed">21872769</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspinall R., Andrew D. Thymic involution in aging. J. Clin. Immunol. 2000;20:250&#x2013;256. doi: 10.1023/A:1006611518223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1006611518223</ArticleId><ArticleId IdType="pubmed">10939712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell W.A., Lang P.O., Aspinall R. Tracing thymic output in older individuals. Clin. Exp. Immunol. 2010;161:497&#x2013;503. doi: 10.1111/j.1365-2249.2010.04209.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2010.04209.x</ArticleId><ArticleId IdType="pmc">PMC2962967</ArticleId><ArticleId IdType="pubmed">20646007</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng N.P. Aging of the immune system: How much can the adaptive immune system adapt? Immunity. 2006;24:495&#x2013;499. doi: 10.1016/j.immuni.2006.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.05.001</ArticleId><ArticleId IdType="pmc">PMC2266981</ArticleId><ArticleId IdType="pubmed">16713964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro M.P. Age-Associated B Cells. Annu. Rev. Immunol. 2020;38:315&#x2013;340. doi: 10.1146/annurev-immunol-092419-031130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-092419-031130</ArticleId><ArticleId IdType="pubmed">31986068</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D., Diaz A., Romero M., Blomberg B.B. The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations. Vaccine. 2016;34:2834&#x2013;2840. doi: 10.1016/j.vaccine.2016.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.04.023</ArticleId><ArticleId IdType="pmc">PMC4876633</ArticleId><ArticleId IdType="pubmed">27108193</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucher N., Dufeu-Duchesne T., Vicaut E., Farge D., Effros R.B., Schachter F. CD28 expression in T cell aging and human longevity. Exp. Gerontol. 1998;33:267&#x2013;282. doi: 10.1016/S0531-5565(97)00132-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(97)00132-0</ArticleId><ArticleId IdType="pubmed">9615924</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo A.N. CD28 extinction in human T cells: Altered functions and the program of T-cell senescence. Immunol. Rev. 2005;205:158&#x2013;169. doi: 10.1111/j.0105-2896.2005.00256.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00256.x</ArticleId><ArticleId IdType="pubmed">15882352</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank C.U., Haining W.N., Held W., Hogan P.G., Kallies A., Lugli E., Lynn R.C., Philip M., Rao A., Restifo N.P., et al. Defining &#x2018;T cell exhaustion&#x2019;. Nat. Rev. Immunol. 2019;19:665&#x2013;674. doi: 10.1038/s41577-019-0221-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0221-9</ArticleId><ArticleId IdType="pmc">PMC7286441</ArticleId><ArticleId IdType="pubmed">31570879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry E.J. T cell exhaustion. Nat. Immunol. 2011;12:492&#x2013;499. doi: 10.1038/ni.2035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2035</ArticleId><ArticleId IdType="pubmed">21739672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010;22:507&#x2013;513. doi: 10.1016/j.coi.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC4034446</ArticleId><ArticleId IdType="pubmed">20667703</ArticleId></ArticleIdList></Reference><Reference><Citation>Masselli E., Vaccarezza M., Carubbi C., Pozzi G., Presta V., Mirandola P., Vitale M. NK cells: A double edge sword against SARS-CoV-2. Adv. Biol. Regul. 2020;77:100737. doi: 10.1016/j.jbior.2020.100737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2020.100737</ArticleId><ArticleId IdType="pmc">PMC7292949</ArticleId><ArticleId IdType="pubmed">32773100</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eeden C., Khan L., Osman M.S., Cohen Tervaert J.W. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int. J. Mol. Sci. 2020;21:6351. doi: 10.3390/ijms21176351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176351</ArticleId><ArticleId IdType="pmc">PMC7503862</ArticleId><ArticleId IdType="pubmed">32883007</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler S., Zimmermann H.W., Bartneck M., Trautwein C., Tacke F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol. 2010;11:30. doi: 10.1186/1471-2172-11-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-11-30</ArticleId><ArticleId IdType="pmc">PMC2910032</ArticleId><ArticleId IdType="pubmed">20565954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C., Goldstein D.R. Impact of aging on antigen presentation cell function of dendritic cells. Curr. Opin. Immunol. 2013;25:535&#x2013;541. doi: 10.1016/j.coi.2013.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2013.05.016</ArticleId><ArticleId IdType="pmc">PMC3775944</ArticleId><ArticleId IdType="pubmed">23806201</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Garagnani P., Vitale G., Capri M., Salvioli S. Inflammaging and &#x2018;Garb-aging&#x2019;. Trends Endocrinol. Metab. 2017;28:199&#x2013;212. doi: 10.1016/j.tem.2016.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2016.09.005</ArticleId><ArticleId IdType="pubmed">27789101</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R., Wang W., Su D.M. Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging. Immun. Ageing. 2020;17:2. doi: 10.1186/s12979-020-0173-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-0173-8</ArticleId><ArticleId IdType="pmc">PMC6971920</ArticleId><ArticleId IdType="pubmed">31988649</ArticleId></ArticleIdList></Reference><Reference><Citation>Soegiarto G., Purnomosari D. Challenges in the Vaccination of the Elderly and Strategies for Improvement. Pathophysiology. 2023;30:155&#x2013;173. doi: 10.3390/pathophysiology30020014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology30020014</ArticleId><ArticleId IdType="pmc">PMC10204411</ArticleId><ArticleId IdType="pubmed">37218912</ArticleId></ArticleIdList></Reference><Reference><Citation>Pera A., Campos C., Lopez N., Hassouneh F., Alonso C., Tarazona R., Solana R. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 2015;82:50&#x2013;55. doi: 10.1016/j.maturitas.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2015.05.004</ArticleId><ArticleId IdType="pubmed">26044074</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Pawelec G., Cohen A.A., Provost G., Khalil A., Lacombe G., Rodrigues S., Desroches M., Hirokawa K., et al. Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change. Vaccines. 2022;10:607. doi: 10.3390/vaccines10040607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040607</ArticleId><ArticleId IdType="pmc">PMC9030923</ArticleId><ArticleId IdType="pubmed">35455356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira B., Xu X.N., Akbar A.N. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front. Immunol. 2020;11:583019. doi: 10.3389/fimmu.2020.583019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.583019</ArticleId><ArticleId IdType="pmc">PMC7592394</ArticleId><ArticleId IdType="pubmed">33178213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.S., Bellantuono I., Lord J.M., Sapey E., Mannick J.B., Partridge L., Gordon A.L., Steves C.J., Witham M.D. Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. Lancet Healthy Longev. 2020;1:e55&#x2013;e57. doi: 10.1016/S2666-7568(20)30011-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(20)30011-8</ArticleId><ArticleId IdType="pmc">PMC7834195</ArticleId><ArticleId IdType="pubmed">33521768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G., Weng N.P. Can an effective SARS-CoV-2 vaccine be developed for the older population? Immun. Ageing. 2020;17:8. doi: 10.1186/s12979-020-00180-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00180-2</ArticleId><ArticleId IdType="pmc">PMC7148425</ArticleId><ArticleId IdType="pubmed">32300370</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun. Ageing. 2021;18:38. doi: 10.1186/s12979-021-00249-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-021-00249-6</ArticleId><ArticleId IdType="pmc">PMC8501352</ArticleId><ArticleId IdType="pubmed">34627326</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: Is it infectious? Immunol. Rev. 2005;205:257&#x2013;268. doi: 10.1111/j.0105-2896.2005.00271.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00271.x</ArticleId><ArticleId IdType="pubmed">15882359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J., Knox K.S., Rios C.T., Natt B., Bhattacharya D., Fain M.J. SARS-CoV-2 and COVID-19 in older adults: What we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42:505&#x2013;514. doi: 10.1007/s11357-020-00186-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>Torales J., O&#x2019;Higgins M., Castaldelli-Maia J.M., Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int. J. Soc. Psychiatry. 2020;66:317&#x2013;320. doi: 10.1177/0020764020915212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764020915212</ArticleId><ArticleId IdType="pubmed">32233719</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk L.E., Binkhorst M., Bourgonje A.R., Offringa A.K., Mulder D.J., Bos E.M., Kolundzic N., Abdulle A.E., van der Voort P.H., Olde Rikkert M.G., et al. COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options. J. Pathol. 2021;254:307&#x2013;331. doi: 10.1002/path.5642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5642</ArticleId><ArticleId IdType="pmc">PMC8013908</ArticleId><ArticleId IdType="pubmed">33586189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Gao Y., Wang G., Song G., Liu S., Sun D., Xu Y., Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. Mol. Immunol. 2020;17:533&#x2013;535. doi: 10.1038/s41423-020-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Liu X., Le W., Xie L., Li H., Wen W., Wang S., Ma S., Huang Z., Ye J., et al. A human circulating immune cell landscape in aging and COVID-19. Protein Cell. 2020;11:740&#x2013;770. doi: 10.1007/s13238-020-00762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00762-2</ArticleId><ArticleId IdType="pmc">PMC7417788</ArticleId><ArticleId IdType="pubmed">32780218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang C., Peng M. Aging Immune System and Its Correlation With Liability to Severe Lung Complications. Front. Public Health. 2021;9:735151. doi: 10.3389/fpubh.2021.735151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.735151</ArticleId><ArticleId IdType="pmc">PMC8650611</ArticleId><ArticleId IdType="pubmed">34888279</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe T.A., Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013;9:519&#x2013;528. doi: 10.2217/ahe.13.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ahe.13.38</ArticleId><ArticleId IdType="pmc">PMC3878051</ArticleId><ArticleId IdType="pubmed">24391677</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbe J.C., Pepin F., Pelissier F.A., Sputova K., Fridriksdottir A.J., Guo D.E., Villadsen R., Park M., Petersen O.W., Borowsky A.D., et al. Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res. 2012;72:3687&#x2013;3701. doi: 10.1158/0008-5472.CAN-12-0157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-0157</ArticleId><ArticleId IdType="pmc">PMC3399034</ArticleId><ArticleId IdType="pubmed">22552289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelissier Vatter F.A., Schapiro D., Chang H., Borowsky A.D., Lee J.K., Parvin B., Stampfer M.R., LaBarge M.A., Bodenmiller B., Lorens J.B. High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia. Cell Rep. 2018;23:1205&#x2013;1219. doi: 10.1016/j.celrep.2018.03.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.114</ArticleId><ArticleId IdType="pmc">PMC5946804</ArticleId><ArticleId IdType="pubmed">29694896</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sanoff H.K., Cho H., Burd C.E., Torrice C., Ibrahim J.G., Thomas N.E., Sharpless N.E. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8:439&#x2013;448. doi: 10.1111/j.1474-9726.2009.00489.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2009.00489.x</ArticleId><ArticleId IdType="pmc">PMC2752333</ArticleId><ArticleId IdType="pubmed">19485966</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyand C.M., Fulbright J.W., Goronzy J.J. Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp. Gerontol. 2003;38:833&#x2013;841. doi: 10.1016/S0531-5565(03)00090-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(03)00090-1</ArticleId><ArticleId IdType="pubmed">12915205</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya-Ortiz G. Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis. 2013;2013:267078. doi: 10.1155/2013/267078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/267078</ArticleId><ArticleId IdType="pmc">PMC3821895</ArticleId><ArticleId IdType="pubmed">24260712</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Garagnani P., Parini P., Giuliani C., Santoro A. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 2018;14:576&#x2013;590. doi: 10.1038/s41574-018-0059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdaens O., van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front. Neurol. 2021;12:811518. doi: 10.3389/fneur.2021.811518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.811518</ArticleId><ArticleId IdType="pmc">PMC8913495</ArticleId><ArticleId IdType="pubmed">35281989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T.V., Sato Y., Goronzy J.J., Weyand C.M. T-Cell Aging-Associated Phenotypes in Autoimmune Disease. Front. Aging. 2022;3:867950. doi: 10.3389/fragi.2022.867950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2022.867950</ArticleId><ArticleId IdType="pmc">PMC9261367</ArticleId><ArticleId IdType="pubmed">35821833</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S. From aging to long COVID: Exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front. Immunol. 2023;14:1298004. doi: 10.3389/fimmu.2023.1298004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1298004</ArticleId><ArticleId IdType="pmc">PMC10628127</ArticleId><ArticleId IdType="pubmed">37942323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prelog M. Aging of the immune system: A risk factor for autoimmunity? Autoimmun. Rev. 2006;5:136&#x2013;139. doi: 10.1016/j.autrev.2005.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2005.09.008</ArticleId><ArticleId IdType="pubmed">16431345</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole E., Sinclair J. Sleepless latency of human cytomegalovirus. Med. Microbiol. Immunol. 2015;204:421&#x2013;429. doi: 10.1007/s00430-015-0401-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-015-0401-6</ArticleId><ArticleId IdType="pmc">PMC4439429</ArticleId><ArticleId IdType="pubmed">25772624</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte E., Zhang Z., Thorp E.B., Hummel M. Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front. Cell Infect Microbiol. 2020;10:130. doi: 10.3389/fcimb.2020.00130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00130</ArticleId><ArticleId IdType="pmc">PMC7136410</ArticleId><ArticleId IdType="pubmed">32296651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu W., Rao S. Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection. Front. Microbiol. 2016;7:2111. doi: 10.3389/fmicb.2016.02111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.02111</ArticleId><ArticleId IdType="pmc">PMC5186782</ArticleId><ArticleId IdType="pubmed">28082969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Lofgren S., Nilsson B.O., Ernerudh J., Pawelec G., Johansson B. An immune risk phenotype, cognitive impairment, and survival in very late life: Impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:556&#x2013;565. doi: 10.1093/gerona/60.5.556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/60.5.556</ArticleId><ArticleId IdType="pubmed">15972602</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodrum F. Human Cytomegalovirus Latency: Approaching the Gordian Knot. Annu. Rev. Virol. 2016;3:333&#x2013;357. doi: 10.1146/annurev-virology-110615-042422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042422</ArticleId><ArticleId IdType="pmc">PMC5514425</ArticleId><ArticleId IdType="pubmed">27501258</ArticleId></ArticleIdList></Reference><Reference><Citation>Balthesen M., Dreher L., Lucin P., Reddehase M.J. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. Pt 9J. Gen. Virol. 1994;75:2329&#x2013;2336. doi: 10.1099/0022-1317-75-9-2329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-75-9-2329</ArticleId><ArticleId IdType="pubmed">8077931</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor C.M. Cytomegalovirus (CMV) Infection and Latency. Pathogens. 2021;10:342. doi: 10.3390/pathogens10030342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10030342</ArticleId><ArticleId IdType="pmc">PMC8001800</ArticleId><ArticleId IdType="pubmed">33804183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont L., Reeves M.B. Cytomegalovirus latency and reactivation: Recent insights into an age old problem. Rev. Med. Virol. 2016;26:75&#x2013;89. doi: 10.1002/rmv.1862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1862</ArticleId><ArticleId IdType="pmc">PMC5458136</ArticleId><ArticleId IdType="pubmed">26572645</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. Pt 9J. Gen. Virol. 1991;72:2059&#x2013;2064. doi: 10.1099/0022-1317-72-9-2059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-72-9-2059</ArticleId><ArticleId IdType="pubmed">1654370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills M.R., Poole E., Lau B., Krishna B., Sinclair J.H. The immunology of human cytomegalovirus latency: Could latent infection be cleared by novel immunotherapeutic strategies? Cell. Mol. Immunol. 2015;12:128&#x2013;138. doi: 10.1038/cmi.2014.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.75</ArticleId><ArticleId IdType="pmc">PMC4654298</ArticleId><ArticleId IdType="pubmed">25132454</ArticleId></ArticleIdList></Reference><Reference><Citation>Seckert C.K., Renzaho A., Tervo H.M., Krause C., Deegen P., Kuhnapfel B., Reddehase M.J., Grzimek N.K. Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J. Virol. 2009;83:8869&#x2013;8884. doi: 10.1128/JVI.00870-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00870-09</ArticleId><ArticleId IdType="pmc">PMC2738169</ArticleId><ArticleId IdType="pubmed">19535440</ArticleId></ArticleIdList></Reference><Reference><Citation>Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 1993;67:5360&#x2013;5366. doi: 10.1128/jvi.67.9.5360-5366.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.9.5360-5366.1993</ArticleId><ArticleId IdType="pmc">PMC237936</ArticleId><ArticleId IdType="pubmed">8394453</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J., Cicin-Sain L., Collins-McMillen D., Jackson S., Oxenius A., Sinclair J., Snyder C., Wills M., Lemmermann N. Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging. Geroscience. 2020;42:495&#x2013;504. doi: 10.1007/s11357-020-00170-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00170-8</ArticleId><ArticleId IdType="pmc">PMC7205956</ArticleId><ArticleId IdType="pubmed">32162210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pera A., Campos C., Corona A., Sanchez-Correa B., Tarazona R., Larbi A., Solana R. CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS ONE. 2014;9:e88538. doi: 10.1371/journal.pone.0088538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088538</ArticleId><ArticleId IdType="pmc">PMC3922920</ArticleId><ArticleId IdType="pubmed">24533103</ArticleId></ArticleIdList></Reference><Reference><Citation>Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., Asher T.E., Douek D.C., Harari A., Pantaleo G., et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 2007;204:1405&#x2013;1416. doi: 10.1084/jem.20062363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20062363</ArticleId><ArticleId IdType="pmc">PMC2118607</ArticleId><ArticleId IdType="pubmed">17535971</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos Rocha C., Hirao L.A., Weber M.G., Mendez-Lagares G., Chang W.L.W., Jiang G., Deere J.D., Sparger E.E., Roberts J., Barry P.A., et al. Subclinical Cytomegalovirus Infection Is Associated with Altered Host Immunity, Gut Microbiota, and Vaccine Responses. J. Virol. 2018;92:10&#x2013;1128. doi: 10.1128/JVI.00167-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00167-18</ArticleId><ArticleId IdType="pmc">PMC6002712</ArticleId><ArticleId IdType="pubmed">29669841</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo A.N., Brandes J.C., Weyand C.M., Goronzy J.R.J. Modulation of CD28 Expression: Distinct Regulatory Pathways During Activation and Replicative Senescence1. J. Immunol. 1999;162:6572&#x2013;6579. doi: 10.4049/jimmunol.162.11.6572.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.162.11.6572</ArticleId><ArticleId IdType="pubmed">10352273</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Heredia P., Reina-Alfonso I., Dominguez-Del-Castillo J.J., Gutierrez-Gonzalez C., Hassouneh F., Batista-Duharte A., Perez A.B., Tarazona R., Solana R., Pera A. Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2023;228:576&#x2013;585. doi: 10.1093/infdis/jiad119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad119</ArticleId><ArticleId IdType="pmc">PMC10469128</ArticleId><ArticleId IdType="pubmed">37103009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005;202:673&#x2013;685. doi: 10.1084/jem.20050882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050882</ArticleId><ArticleId IdType="pmc">PMC2212883</ArticleId><ArticleId IdType="pubmed">16147978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., thor Straten P., Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 2006;176:2645&#x2013;2653. doi: 10.4049/jimmunol.176.4.2645.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.4.2645</ArticleId><ArticleId IdType="pubmed">16456027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotival M., Quintana-Murci L. Environmental variation and genetic diversity contribute to population differences in immune responses to SARS-CoV-2 and COVID-19 risk. Genes Immun. 2023:1&#x2013;3. doi: 10.1038/s41435-023-00249-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-023-00249-0</ArticleId><ArticleId IdType="pubmed">38142268</ArticleId></ArticleIdList></Reference><Reference><Citation>Liston A., Carr E.J., Linterman M.A. Shaping Variation in the Human Immune System. Trends Immunol. 2016;37:637&#x2013;646. doi: 10.1016/j.it.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2016.08.002</ArticleId><ArticleId IdType="pubmed">27692231</ArticleId></ArticleIdList></Reference><Reference><Citation>Liston A., Humblet-Baron S., Duffy D., Goris A. Human immune diversity: From evolution to modernity. Nat. Immunol. 2021;22:1479&#x2013;1489. doi: 10.1038/s41590-021-01058-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01058-1</ArticleId><ArticleId IdType="pubmed">34795445</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldeck D., Larsen L.A., Christensen K., Hamprecht K., Ottinger L., Hahnel K., Pawelec G. Impact of Cytomegalovirus Infection and Genetic Background on the Frequencies of Peripheral Blood Suppressor Cells in Human Twins. Pathogens. 2021;10:963. doi: 10.3390/pathogens10080963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10080963</ArticleId><ArticleId IdType="pmc">PMC8399020</ArticleId><ArticleId IdType="pubmed">34451427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi-Rad M., Anil Kumar N.V., Zucca P., Varoni E.M., Dini L., Panzarini E., Rajkovic J., Tsouh Fokou P.V., Azzini E., Peluso I., et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020;11:694. doi: 10.3389/fphys.2020.00694.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00694</ArticleId><ArticleId IdType="pmc">PMC7347016</ArticleId><ArticleId IdType="pubmed">32714204</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Campisi J., Verdin E., Carrera-Bastos P., Targ S., Franceschi C., Ferrucci L., Gilroy D.W., Fasano A., Miller G.W., et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019;25:1822&#x2013;1832. doi: 10.1038/s41591-019-0675-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel M., Abecassis M.M. A model for reactivation of CMV from latency. J. Clin. Virol. 2002;25((Suppl. 2)):S123&#x2013;S136. doi: 10.1016/S1386-6532(02)00088-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(02)00088-4</ArticleId><ArticleId IdType="pubmed">12361763</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosch S., Staak K., Stein J., Liebenthal C., Stamminger T., Volk H.D., Kruger D.H. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology. 1995;208:197&#x2013;206. doi: 10.1006/viro.1995.1143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1143</ArticleId><ArticleId IdType="pubmed">11831701</ArticleId></ArticleIdList></Reference><Reference><Citation>Haspot F., Lavault A., Sinzger C., Laib Sampaio K., Stierhof Y.D., Pilet P., Bressolette-Bodin C., Halary F. Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS ONE. 2012;7:e34795. doi: 10.1371/annotation/d12b8d83-7c45-4661-908d-d7e5a3c9b226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/d12b8d83-7c45-4661-908d-d7e5a3c9b226</ArticleId><ArticleId IdType="pmc">PMC3322158</ArticleId><ArticleId IdType="pubmed">22496863</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R.B., Jr. The &#x2018;indirect&#x2019; effects of cytomegalovirus infection. Am. J. Transplant. 2009;9:2453&#x2013;2458. doi: 10.1111/j.1600-6143.2009.02824.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2009.02824.x</ArticleId><ArticleId IdType="pubmed">19843027</ArticleId></ArticleIdList></Reference><Reference><Citation>Solana R., Tarazona R., Aiello A.E., Akbar A.N., Appay V., Beswick M., Bosch J.A., Campos C., Cantisan S., Cicin-Sain L., et al. CMV and Immunosenescence: From basics to clinics. Immun. Ageing. 2012;9:23. doi: 10.1186/1742-4933-9-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-9-23</ArticleId><ArticleId IdType="pmc">PMC3585851</ArticleId><ArticleId IdType="pubmed">23114110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y.L., Lin C.H., Sung B.Y., Chuang Y.F., Schneck J.P., Kern F., Pawelec G., Wang G.C. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4+ and CD8+ T-cell responses in older adults positively correlates with response size. Sci. Rep. 2016;6:19227. doi: 10.1038/srep19227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19227</ArticleId><ArticleId IdType="pmc">PMC4726016</ArticleId><ArticleId IdType="pubmed">26778409</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A.E., Chiu Y.L., Frasca D. How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms? Geroscience. 2017;39:261&#x2013;271. doi: 10.1007/s11357-017-9983-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-017-9983-9</ArticleId><ArticleId IdType="pmc">PMC5505887</ArticleId><ArticleId IdType="pubmed">28624868</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahame-Clarke C., Chan N.N., Andrew D., Ridgway G.L., Betteridge D.J., Emery V., Colhoun H.M., Vallance P. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 2003;108:678&#x2013;683. doi: 10.1161/01.CIR.0000084505.54603.C7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000084505.54603.C7</ArticleId><ArticleId IdType="pubmed">12900349</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE. 2011;6:e16103. doi: 10.1371/journal.pone.0016103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016103</ArticleId><ArticleId IdType="pmc">PMC3040745</ArticleId><ArticleId IdType="pubmed">21379581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy R.P., Doyle M.F., Olson N.C., Huber S.A., Jenny N.S., Sallam R., Psaty B.M., Kronmal R.A. T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. J. Am. Heart Assoc. 2013;2:e000117. doi: 10.1161/JAHA.113.000117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000117</ArticleId><ArticleId IdType="pmc">PMC3698770</ArticleId><ArticleId IdType="pubmed">23688675</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs B.G., Baker D.J., Wijshake T., Conover C.A., Campisi J., van Deursen J.M. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016;354:472&#x2013;477. doi: 10.1126/science.aaf6659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6659</ArticleId><ArticleId IdType="pmc">PMC5112585</ArticleId><ArticleId IdType="pubmed">27789842</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaoud Z., Riou R., Gavlovsky P.J., Mehlal S., Bressollette C., Gerard N., Gagne K., Charreau B., Retiere C. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells. J. Innate. Immun. 2016;8:374&#x2013;385. doi: 10.1159/000445320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000445320</ArticleId><ArticleId IdType="pmc">PMC6738823</ArticleId><ArticleId IdType="pubmed">27116381</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadley I., Pera A., Morrow G., Davies K.A., Kern F. Expansions of Cytotoxic CD4(+)CD28(&#x2212;) T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection. Front. Immunol. 2017;8:195. doi: 10.3389/fimmu.2017.00195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00195</ArticleId><ArticleId IdType="pmc">PMC5332470</ArticleId><ArticleId IdType="pubmed">28303136</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D.G. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007;204:2449&#x2013;2460. doi: 10.1084/jem.20070657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070657</ArticleId><ArticleId IdType="pmc">PMC2118469</ArticleId><ArticleId IdType="pubmed">17875676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachnio A., Ciaurriz M., Begum J., Lal N., Zuo J., Beggs A., Moss P. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832. doi: 10.1371/journal.ppat.1005832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005832</ArticleId><ArticleId IdType="pmc">PMC5015996</ArticleId><ArticleId IdType="pubmed">27606804</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis M., Kledal T.N., Lin K.Y., Panchal S.N., Gao S.Z., Valantine H.A., Mocarski E.S., Cooke J.P. Cytomegalovirus infection impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation. 2004;109:500&#x2013;505. doi: 10.1161/01.CIR.0000109692.16004.AF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000109692.16004.AF</ArticleId><ArticleId IdType="pubmed">14732750</ArticleId></ArticleIdList></Reference><Reference><Citation>Firth C., Harrison R., Ritchie S., Wardlaw J., Ferro C.J., Starr J.M., Deary I.J., Moss P. Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals. QJM. 2016;109:595&#x2013;600. doi: 10.1093/qjmed/hcw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcw026</ArticleId><ArticleId IdType="pmc">PMC5027953</ArticleId><ArticleId IdType="pubmed">27071749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J., Ke Q., Jin Z., Wang H., Kocher O., Morgan J.P., Zhang J., Crumpacker C.S. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 2009;5:e1000427. doi: 10.1371/journal.ppat.1000427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000427</ArticleId><ArticleId IdType="pmc">PMC2673691</ArticleId><ArticleId IdType="pubmed">19436702</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz N., Minton S., Cox C., Bowman T., Gritsko T., Garcia R., Eweis I., Wloch M., Livingston S., Seijo E., et al. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin. Cancer Res. 2006;12:20&#x2013;28. doi: 10.1158/1078-0432.CCR-04-1749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-04-1749</ArticleId><ArticleId IdType="pubmed">16397019</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbein G., Kumar A. The oncogenic potential of human cytomegalovirus and breast cancer. Front. Oncol. 2014;4:230. doi: 10.3389/fonc.2014.00230.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2014.00230</ArticleId><ArticleId IdType="pmc">PMC4142708</ArticleId><ArticleId IdType="pubmed">25202681</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B., Wang X., Chen E., Zhu H. Human cytomegalovirus infection and colorectal cancer risk: A meta-analysis. Oncotarget. 2016;7:76735&#x2013;76742. doi: 10.18632/oncotarget.12523.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.12523</ArticleId><ArticleId IdType="pmc">PMC5363545</ArticleId><ArticleId IdType="pubmed">27732934</ArticleId></ArticleIdList></Reference><Reference><Citation>McFaline-Figueroa J.R., Wen P.Y. The Viral Connection to Glioblastoma. Curr. Infect. Dis. Rep. 2017;19:5. doi: 10.1007/s11908-017-0563-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-017-0563-z</ArticleId><ArticleId IdType="pubmed">28233187</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta M., Harkins L., Klemm K., Britt W.J., Cobbs C.S. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 2003;170:998&#x2013;1002. doi: 10.1097/01.ju.0000080263.46164.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ju.0000080263.46164.97</ArticleId><ArticleId IdType="pubmed">12913758</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D., Quadri M., Gangane N., Joshi R., Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS ONE. 2009;4:e8180. doi: 10.1371/journal.pone.0008180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008180</ArticleId><ArticleId IdType="pmc">PMC2782138</ArticleId><ArticleId IdType="pubmed">19997605</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbein G. The Human Cytomegalovirus, from Oncomodulation to Oncogenesis. Viruses. 2018;10:408. doi: 10.3390/v10080408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10080408</ArticleId><ArticleId IdType="pmc">PMC6115842</ArticleId><ArticleId IdType="pubmed">30081496</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., Nabors L.B., Cobbs C.G., Britt W.J. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347&#x2013;3350.</Citation><ArticleIdList><ArticleId IdType="pubmed">12067971</ArticleId></ArticleIdList></Reference><Reference><Citation>El Baba R., Pasquereau S., Haidar Ahmad S., Monnien F., Abad M., Bibeau F., Herbein G. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene. 2023;42:2031&#x2013;2045. doi: 10.1038/s41388-023-02709-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-023-02709-3</ArticleId><ArticleId IdType="pmc">PMC10256614</ArticleId><ArticleId IdType="pubmed">37147437</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelis M., Doerr H.W., Cinatl J. The story of human cytomegalovirus and cancer: Increasing evidence and open questions. Neoplasia. 2009;11:1&#x2013;9. doi: 10.1593/neo.81178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/neo.81178</ArticleId><ArticleId IdType="pmc">PMC2606113</ArticleId><ArticleId IdType="pubmed">19107226</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., Cobbs C.S. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002;360:1557&#x2013;1563. doi: 10.1016/S0140-6736(02)11524-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)11524-8</ArticleId><ArticleId IdType="pubmed">12443594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C., He S., Zhu W., Ru P., Ge X., Govindasamy K. Human cytomegalovirus in cancer: The mechanism of HCMV-induced carcinogenesis and its therapeutic potential. Front. Cell. Infect. Microbiol. 2023;13:1202138. doi: 10.3389/fcimb.2023.1202138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1202138</ArticleId><ArticleId IdType="pmc">PMC10327488</ArticleId><ArticleId IdType="pubmed">37424781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas K.G., Bao L., Bruggeman R., Dunham K., Specht C. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J. Neurooncol. 2011;103:231&#x2013;238. doi: 10.1007/s11060-010-0383-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-010-0383-6</ArticleId><ArticleId IdType="pubmed">20820869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M., Dastmalchi F., Karachi A., Mitchell D. The role of CMV in glioblastoma and implications for immunotherapeutic strategies. Oncoimmunology. 2019;8:e1514921. doi: 10.1080/2162402X.2018.1514921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2018.1514921</ArticleId><ArticleId IdType="pmc">PMC6287786</ArticleId><ArticleId IdType="pubmed">30546954</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornara O., Odeberg J., Wolmer Solberg N., Tammik C., Skarman P., Peredo I., Stragliotto G., Rahbar A., Soderberg-Naucler C. Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery. Oncoimmunology. 2015;4:e1036211. doi: 10.1080/2162402X.2015.1036211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2015.1036211</ArticleId><ArticleId IdType="pmc">PMC4570117</ArticleId><ArticleId IdType="pubmed">26405601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Ford B.N., Kuplicki R., Burrows K., Hunt P.W., Bodurka J., Kent Teague T., Irwin M.R., Yolken R.H., Paulus M.P., et al. Association between cytomegalovirus infection, reduced gray matter volume, and resting-state functional hypoconnectivity in major depressive disorder: A replication and extension. Transl. Psychiatry. 2021;11:464. doi: 10.1038/s41398-021-01558-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01558-6</ArticleId><ArticleId IdType="pmc">PMC8423754</ArticleId><ArticleId IdType="pubmed">34493708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribalta T., Martinez A.J., Jares P., Muntane J., Miquel R., Claramonte X., Cardesa A. Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation. An autopsy study of 83 cases. Virchows Arch. 2002;440:166&#x2013;171. doi: 10.1007/s004280100497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004280100497</ArticleId><ArticleId IdType="pubmed">11964047</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A.E., Haan M., Blythe L., Moore K., Gonzalez J.M., Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J. Am. Geriatr. Soc. 2006;54:1046&#x2013;1054. doi: 10.1111/j.1532-5415.2006.00796.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2006.00796.x</ArticleId><ArticleId IdType="pubmed">16866674</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S., M&#xfc;ller L., Rauskolb S., Sendtner M., Deutschbein T., Pawelec G., Muller V. Network topology dynamics of circulating biomarkers and cognitive performance in older Cytomegalovirus-seropositive or -seronegative men and women. Immun. Ageing. 2019;16:31. doi: 10.1186/s12979-019-0171-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0171-x</ArticleId><ArticleId IdType="pmc">PMC6894301</ArticleId><ArticleId IdType="pubmed">31827568</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgdorf K.S., Trabjerg B.B., Pedersen M.G., Nissen J., Banasik K., Pedersen O.B., Sorensen E., Nielsen K.R., Larsen M.H., Erikstrup C., et al. Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders. Brain Behav. Immun. 2019;79:152&#x2013;158. doi: 10.1016/j.bbi.2019.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.01.026</ArticleId><ArticleId IdType="pubmed">30685531</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips A.C., Carroll D., Khan N., Moss P. Cytomegalovirus is associated with depression and anxiety in older adults. Brain Behav. Immun. 2008;22:52&#x2013;55. doi: 10.1016/j.bbi.2007.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.06.012</ArticleId><ArticleId IdType="pubmed">17703915</ArticleId></ArticleIdList></Reference><Reference><Citation>Houenou J., d&#x2019;Albis M.A., Daban C., Hamdani N., Delavest M., Lepine J.P., Vederine F.E., Carde S., Lajnef M., Cabon C., et al. Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;48:142&#x2013;148. doi: 10.1016/j.pnpbp.2013.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2013.09.003</ArticleId><ArticleId IdType="pubmed">24083998</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone I., Lazzarotto T., Ianni M., Porcellini E., Forti P., Masliah E., Gabrielli L., Licastro F. Herpes virus in Alzheimer&#x2019;s disease: Relation to progression of the disease. Neurobiol. Aging. 2014;35:122&#x2013;129. doi: 10.1016/j.neurobiolaging.2013.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.06.024</ArticleId><ArticleId IdType="pubmed">23916950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W.R., Wozniak M.A., Wilcock G.K., Itzhaki R.F. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol. Dis. 2002;9:82&#x2013;87. doi: 10.1006/nbdi.2001.0465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0465</ArticleId><ArticleId IdType="pubmed">11848687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav. Immun. 2001;15:199&#x2013;226. doi: 10.1006/brbi.2000.0597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/brbi.2000.0597</ArticleId><ArticleId IdType="pubmed">11566046</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D.L., Ten Have T.R., Douglas S.D., Gettes D.R., Morrison M., Chiappini M.S., Brinker-Spence P., Job C., Mercer D.E., Wang Y.L., et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am. J. Psychiatry. 2002;159:1752&#x2013;1759. doi: 10.1176/appi.ajp.159.10.1752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.159.10.1752</ArticleId><ArticleId IdType="pubmed">12359683</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918&#x2013;934. doi: 10.1016/j.cell.2010.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.016</ArticleId><ArticleId IdType="pmc">PMC2873093</ArticleId><ArticleId IdType="pubmed">20303880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gow A.J., Firth C.M., Harrison R., Starr J.M., Moss P., Deary I.J. Cytomegalovirus infection and cognitive abilities in old age. Neurobiol. Aging. 2013;34:1846&#x2013;1852. doi: 10.1016/j.neurobiolaging.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.01.011</ArticleId><ArticleId IdType="pubmed">23434472</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbins R.C., Noppert G.A., Yang Y.C., Dowd J.B., Simanek A., Aiello A.E. Association Between Immune Response to Cytomegalovirus and Cognition in the Health and Retirement Study. Am. J. Epidemiol. 2021;190:786&#x2013;797. doi: 10.1093/aje/kwaa238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwaa238</ArticleId><ArticleId IdType="pmc">PMC8096487</ArticleId><ArticleId IdType="pubmed">33094810</ArticleId></ArticleIdList></Reference><Reference><Citation>Torniainen-Holm M., Suvisaari J., Lindgren M., Harkanen T., Dickerson F., Yolken R.H. Association of cytomegalovirus and Epstein-Barr virus with cognitive functioning and risk of dementia in the general population: 11-year follow-up study. Brain Behav. Immun. 2018;69:480&#x2013;485. doi: 10.1016/j.bbi.2018.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.01.006</ArticleId><ArticleId IdType="pubmed">29355820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivek S., Nelson H.H., Prizment A.E., Faul J., Crimmins E.M., Thyagarajan B. Cross sectional association between cytomegalovirus seropositivity, inflammation and cognitive impairment in elderly cancer survivors. Cancer Causes Control. 2022;33:81&#x2013;90. doi: 10.1007/s10552-021-01504-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-021-01504-3</ArticleId><ArticleId IdType="pmc">PMC8840815</ArticleId><ArticleId IdType="pubmed">34637066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludlow M., Kortekaas J., Herden C., Hoffmann B., Tappe D., Trebst C., Griffin D.E., Brindle H.E., Solomon T., Brown A.S., et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. 2016;131:159&#x2013;184. doi: 10.1007/s00401-015-1511-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1511-3</ArticleId><ArticleId IdType="pmc">PMC4713712</ArticleId><ArticleId IdType="pubmed">26659576</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleidi M., Isacson O. Viral and inflammatory triggers of neurodegenerative diseases. Sci. Transl. Med. 2012;4:121ps3. doi: 10.1126/scitranslmed.3003492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003492</ArticleId><ArticleId IdType="pmc">PMC3982831</ArticleId><ArticleId IdType="pubmed">22344685</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Ford B.N., Bergamino M., Kuplicki R., Tulsa I., Hunt P.W., Bodurka J., Teague T.K., Irwin M.R., Yolken R.H., et al. A hidden menace? Cytomegalovirus infection is associated with reduced cortical gray matter volume in major depressive disorder. Mol. Psychiatry. 2021;26:4234&#x2013;4244. doi: 10.1038/s41380-020-00932-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00932-y</ArticleId><ArticleId IdType="pmc">PMC8140068</ArticleId><ArticleId IdType="pubmed">33223520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Bergamino M., Ford B.N., Kuplicki R., Yeh F.C., Bodurka J., Burrows K., Tulsa I., Hunt P.W., Teague T.K., et al. Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorder. Neuropsychopharmacology. 2021;46:928&#x2013;938. doi: 10.1038/s41386-021-00971-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00971-1</ArticleId><ArticleId IdType="pmc">PMC8115597</ArticleId><ArticleId IdType="pubmed">33500556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford B.N., Savitz J. Depression, aging, and immunity: Implications for COVID-19 vaccine immunogenicity. Immun. Ageing. 2022;19:32. doi: 10.1186/s12979-022-00288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-022-00288-7</ArticleId><ArticleId IdType="pmc">PMC9281075</ArticleId><ArticleId IdType="pubmed">35836263</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S., M&#xfc;ller L., Wenger E., Duzel S., Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci. Biobehav. Rev. 2017;75:114&#x2013;128. doi: 10.1016/j.neubiorev.2017.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.044</ArticleId><ArticleId IdType="pubmed">28161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Halenius A., Hengel H. Human cytomegalovirus and autoimmune disease. BioMed Res. Int. 2014;2014:472978. doi: 10.1155/2014/472978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/472978</ArticleId><ArticleId IdType="pmc">PMC4022258</ArticleId><ArticleId IdType="pubmed">24967373</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanio C., Verma A., Mathew D., Gouma S., Liang G., Dunn T., Oldridge D.A., Weaver J., Kuri-Cervantes L., Pampena M.B., et al. Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization. J. Infect. Dis. 2022;226:463&#x2013;473. doi: 10.1093/infdis/jiac020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac020</ArticleId><ArticleId IdType="pmc">PMC8905965</ArticleId><ArticleId IdType="pubmed">35134186</ArticleId></ArticleIdList></Reference><Reference><Citation>Frozza F.T.B., Fazolo T., de Souza P.O., Lima K., da Fontoura J.C., Borba T.S., Polese-Bonatto M., Kern L.B., Stein R.T., Pawelec G., et al. A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production. Med. Microbiol. Immunol. 2023;212:75&#x2013;91. doi: 10.1007/s00430-022-00758-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00758-1</ArticleId><ArticleId IdType="pmc">PMC9745694</ArticleId><ArticleId IdType="pubmed">36512097</ArticleId></ArticleIdList></Reference><Reference><Citation>Vescovini R., Biasini C., Telera A.R., Basaglia M., Stella A., Magalini F., Bucci L., Monti D., Lazzarotto T., Dal Monte P., et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J. Immunol. 2010;184:3242&#x2013;3249. doi: 10.4049/jimmunol.0902890.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902890</ArticleId><ArticleId IdType="pubmed">20173031</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Jojic V., Sharma S., Shen-Orr S.S., Angel C.J., Onengut-Gumuscu S., Kidd B.A., Maecker H.T., Concannon P., Dekker C.L., et al. Cytomegalovirus infection enhances the immune response to influenza. Sci. Transl. Med. 2015;7:281ra43. doi: 10.1126/scitranslmed.aaa2293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa2293</ArticleId><ArticleId IdType="pmc">PMC4505610</ArticleId><ArticleId IdType="pubmed">25834109</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S. Aged brain and neuroimmune responses to COVID-19: Post-acute sequelae and modulatory effects of behavioral and nutritional interventions. Immun. Ageing. 2023;20:17. doi: 10.1186/s12979-023-00341-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-023-00341-z</ArticleId><ArticleId IdType="pmc">PMC10090758</ArticleId><ArticleId IdType="pubmed">37046272</ArticleId></ArticleIdList></Reference><Reference><Citation>Soderberg-Naucler C. Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Immun. Ageing. 2021;18:12. doi: 10.1186/s12979-021-00218-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-021-00218-z</ArticleId><ArticleId IdType="pmc">PMC7952506</ArticleId><ArticleId IdType="pubmed">33712035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., Taylor S., Rayner C., Husain L., Greenhalgh T. Persistent symptoms after Covid-19: Qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv. Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazeldine J., Lord J.M. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front. Immunol. 2020;11:573662. doi: 10.3389/fimmu.2020.573662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.573662</ArticleId><ArticleId IdType="pmc">PMC7573102</ArticleId><ArticleId IdType="pubmed">33123152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartleson J.M., Radenkovic D., Covarrubias A.J., Furman D., Winer D.A., Verdin E. SARS-CoV-2, COVID-19 and the aging immune system. Nat. Aging. 2021;1:769&#x2013;782. doi: 10.1038/s43587-021-00114-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-021-00114-7</ArticleId><ArticleId IdType="pmc">PMC8570568</ArticleId><ArticleId IdType="pubmed">34746804</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43:268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho A.M., Braniff O., Angelova A., Deng Y., Tremblay M.E. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome. Brain Res. Bull. 2023;201:110702. doi: 10.1016/j.brainresbull.2023.110702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2023.110702</ArticleId><ArticleId IdType="pubmed">37423295</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova A.C., Raleva S., Alexandrova D., Capo N., Murovska M., On Behalf Of The European Network On Me/Cfs Euromene Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic small ie, Cyrillicncephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92:3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>